Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERLACE: Induction Chemotherapy in Cervical Cancer
NCT01566240Phase 3Active, not recruiting
- Sponsor
- University College London
- Start
- Nov 2012
- Primary completion
- Feb 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 5
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in Cervical Cancer (CC), sponsored by University College London. Started Nov 2012; status: active, not recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01566240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566240.